Loading AI feed…
TG Therapeutics
Action, confidence, horizon, and decision blockers at a glance.
Fast scan of bull, bear, and watch items
High-level snapshot
Thesis highlights from the latest analysis
Scannable catalysts and supporting factors
Other notable items detected
Next few weeks
Months to a year
| Symbol | Summary |
|---|---|
| MIRM | Mirum is a closer small/mid-cap commercial biopharma comp on go-to-market execution and single-franchise concentration, though its liver-disease focus makes it only a loose operating peer. |
| PTGX | Protagonist is a catalyst-driven smid-cap biotech comp for pipeline milestone sensitivity, but it is less useful than TGTX for commercial MS-franchise benchmarking. |
| GILD | Gilead is a much larger biopharma benchmark for commercialization discipline and lifecycle management, but the scale mismatch limits direct valuation read-through. |
Internal and external references used in this analysis